Clinically aggressive lymphomas are defined by the Revised European-American Classification for lymphoid neoplasms as diffuse large B-cell lymphoma, peripheral T-cell lymphoma, anaplastic large cell lymphoma, and lymphoblastic lymphoma. Mantle cell lymphoma is atypical due to its indolent presentation and refractoriness to treatments. A review of current therapeutic possibilities for these different lymphomas is presented.